CNS Breathe Right Sales, FiberChoice Cuts Produce "Return To Profitability"
This article was originally published in The Tan Sheet
CNS expects FiberChoice to become a $30 mil. product in the long term, which would equate to about 10% of the fiber category, the company said.
You may also be interested in...
CNS aims to increase international sales by up to 20% in 2002 as part of its strategy to boost revenue and continue recent earnings gains
CNS recorded a $1.2 mil. charge against earnings in the second quarter as part of a restructuring plan aimed at strengthening its core Breathe Right nasal strip business and returning the firm to sustainable profitability.
CNS' two new children's Breathe Right nasal strips, now reaching food, drug and mass outlets nationwide, offer a new solution for the "winter woes of a stuffy nose," according to the company.